Source: Annual Congress 2007 - Metabolic consequences of obstructive sleep apnoea
Disease area: Sleep and breathing disorders



Rating:

Share or cite this content

Citations should be made in the following way:
F. Mormile, F. Macagno, T. Schirinzi, A. Petrone, M. Andreani, A. Di Flaviani, M. T. Madeo, P. Borboni (Rome, Italy). Insulin resistance and patterns of continuous glucose monitoring in sleep apnoea patients: relationship with nocturnal hypoxemia and CPAP therapy. Eur Respir J 2007; 30: Suppl. 51, 4107

Member's Comments

No comment yet.

Related content which might interest you: Nocturnal melatonin plasma levels in patients with OSAS: the effect of CPAP Source: Eur Respir J 2007; 30: 496-500 Year: 2007 The effects of non-invasive bilevel positive aiway pressure ventilation on insulin resistance in patients with obstructive sleep apnea Source: Annual Congress 2011 - New evidence in home mechanical ventilation Year: 2011 A study of insulin resistance in moderate to severe obstructive sleep apnea in non diabetics and its response to nasal CPAP treatment Source: Annual Congress 2011 - Cardiometabolic and neurocognitive changes in obstructive sleep apnoea Year: 2011 Cardiac sympathovagal balance during sleep in obstructive sleep apnea patients is different under auto-adjusting CPAP than fixed-CPAP treatment Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea Year: 2006 Continuous positive airway pressure treatment for sleep apnoea: compliance increases with time in continuing users Source: Eur Respir J 2006; 27: 761-766 Year: 2006 Effect of continuous positive airway pressure treatment on hypoadiponectinemia in male patients with obstructive sleep apnea syndrome Source: Annual Congress 2005 - Metabolic control in OSA Year: 2005 The influence of long-term CPAP therapy on metabolic variables in obstructive sleep apnea patients Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Severe sleep apnea, type 2 diabetes and beneficial effects of CPAP on nocturnal glucose control Source: Annual Congress 2008 - Metabolic and sex-related aspects of obstructive sleep apnoea Year: 2008 Is the daily duration of nasal CPAP ventilation the main determinant of improvement of blood gases in OSAS (obstructive sleep apnoea syndrome) patients? Source: Eur Respir J 2001; 18: Suppl. 33, 390s Year: 2001 Adaptive servo-ventilation for the treatment of complex sleep apnea syndrome Source: Annual Congress 2007 - Sleep apnoea and adaptive servo–ventilation Year: 2007 Wrist-actigraphic estimation of sleep time under nCPAP treatment in sleep apnoea patients Source: Eur Respir J 2004; 23: 891-895 Year: 2004 Relationship between aldosterone and the metabolic syndrome in patients with obstructive sleep apnea: Effect of continuous positive airway pressure treatment Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013 Effect of 8 week CPAP therapy on insulin resistance, serum leptin and lipid concentrations among obstructive sleep apnea hypopnea syndrome (OSAS) patients Source: Eur Respir J 2004; 24: Suppl. 48, 330s Year: 2004 Effects of continuous nocturnal high oxygen concentrations in obstructive sleep apnea patients Source: Annual Congress 2005 - Control of breathing Year: 2005 Relationship between apnoea and patient triggered breathing in sleep apnoea patients on nocturnal pressure support Source: Annual Congress 2008 - Noninvasive ventilation in the chronic setting Year: 2008 Efficacy of continuous positive airway pressure treatment to resistant hypertension in patients with obstructive sleep apnea syndrome Source: Annual Congress 2008 - Clinical aspects of continuous positive airway pressure therapy Year: 2008 Compliance in sleep apnoea therapy: influence of home care support and pressure mode Source: Eur Respir J 2009; 33: 804-811 Year: 2009 Metabolic disturbances in patients with obstructive sleep apnoea syndrome Source: Eur Respir Rev 2007; 16: 196-202 Year: 2007 Treatment with CPAP reduces mortality in patients with obstructive sleep apnoea syndrome within less than 3 years Source: Annual Congress 2006 - Therapeutic effects in obstructive sleep apnoea Year: 2006 Cardiovascular and metabolic effects of CPAP in obese males with OSA Source: Eur Respir J 2007; 29: 720-727 Year: 2007